Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy

被引：0
|
作者：
Bhatt, P. [1 ]
Bonomi, P. [1 ]
Basu, S. [2 ]
Batus, M. [1 ]
机构：
[1] Rush Univ, Med Ctr, Sect Med Oncol, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
PROGRESSION FREE SURVIVAL; non small cell lung cancer; Premetrexed;
D O I：
10.1016/j.jtho.2018.08.1565
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-05
引用
收藏
页码：S868 / S869
页数：2
相关论文
共 50 条
  • [41] Pemetrexed long-term maintenance therapy for advanced severe lung cancer with long-term progression-free survival: a case report
    Zhao, Weichao
    Zhu, Minli
    Wang, Ruijuan
    Tong, Zhaohui
    ANTI-CANCER DRUGS, 2023, 34 (05) : 686 - 689
  • [42] Editorial: KRAS in stage IV non-small cell lung cancer
    Noordhof, Anneloes L.
    Blum, Torsten Gerriet
    Hardavella, Georgia
    Hendriks, Lizza E. L.
    van Geffen, Wouter H.
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [43] Maintenance therapy for metastatic non-small-cell lung cancer - the role of pemetrexed
    Katz, Youval
    Somer, Robert A.
    LUNG CANCER-TARGETS AND THERAPY, 2010, 1 : 1 - 7
  • [44] Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy
    Imai, Hisao
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Takahashi, Toshiaki
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [45] Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancer
    Lee, Yunkyoung
    Park, Sojung
    Kim, Woo Sung
    Lee, Jae Cheol
    Jang, Se Jin
    Choi, Jene
    Choi, Chang-Min
    THORACIC CANCER, 2018, 9 (09) : 1104 - 1110
  • [46] Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy
    Hisao Imai
    Keita Mori
    Akira Ono
    Hiroaki Akamatsu
    Tetsuhiko Taira
    Hirotsugu Kenmotsu
    Tateaki Naito
    Kyoichi Kaira
    Haruyasu Murakami
    Masahiro Endo
    Takashi Nakajima
    Toshiaki Takahashi
    Medical Oncology, 2014, 31
  • [47] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    BMC Cancer, 14 (1)
  • [48] Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone
    Zhigang Wei
    Xin Ye
    Xia Yang
    Guanghui Huang
    Wenhong Li
    Jiao Wang
    Xiaoying Han
    Medical Oncology, 2015, 32
  • [49] Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone
    Wei, Zhigang
    Ye, Xin
    Yang, Xia
    Huang, Guanghui
    Li, Wenhong
    Wang, Jiao
    Han, Xiaoying
    MEDICAL ONCOLOGY, 2015, 32 (02)
  • [50] Is long-term survival possible for patients with stage IV ALK plus non-small cell lung cancer?
    Pacheco, Jose M.
    Camidge, David R.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 399 - 401
12345